Indeed, some works have shown that elevated expression of IGF-BP-3 was associated with a shorter time to progression in HNC patients (40) and that levels of IGF factors were found to be maximum in stages with better prognosis in oral cancer (41). This evidence concerns the gene IGF1 and lip and oral cavity carcinoma.